Back
Berkshire Hathaway Vs. Novo Nordisk AS Industry Stock Comparison
Sell
23
BRK.A
Berkshire Hathaway
Last Price:
$683,000.00
Seasonality Move:
6.26%
Sell
29
NVO
Novo Nordisk AS
Last Price:
$87.93
Seasonality Move:
6.4%
Sell
23
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
-
The current Berkshire Hathaway [BRK.A] share price is $680,920.00. The Score for BRK.A is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
BRK.A is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $86.02. The Score for NVO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $680,920.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $86.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BRK.A Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4916.7 | Sell |
Relative Strength Index (14 RSI): | 42.13 | Sell |
Chaikin Money Flow: | 812 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (694582.17 - 694612.17) | Sell |
Bollinger Bands (100): | (688591.18 - 688621.18) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.1 | Sell |
Relative Strength Index (14 RSI): | 26.04 | Sell |
Chaikin Money Flow: | 3954400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.37 - 111.71) | Sell |
Bollinger Bands (100): | (102.88 - 130.98) | Sell |
BRK.A Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 682095.41 | Sell |
20-day SMA: | 688327.06 | Sell |
50-day SMA: | 693773.37 | Sell |
200-day SMA: | 656364.59 | Buy |
8-day EMA: | 682756.65 | Sell |
20-day EMA: | 687714.44 | Sell |
50-day EMA: | 690410.3 | Sell |
200-day EMA: | 656292.89 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.91 | Sell |
20-day SMA: | 100.93 | Sell |
50-day SMA: | 105.5 | Sell |
200-day SMA: | 124.86 | Sell |
8-day EMA: | 90.16 | Sell |
20-day EMA: | 97.16 | Sell |
50-day EMA: | 105.13 | Sell |
200-day EMA: | 116.29 | Sell |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
-
Analysts estimate an earnings increase this quarter of $676.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $327.41 per share, and an increase next year of $1,338.89 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
Berkshire Hathaway Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |